Mihaela Andreescu, MD, PhD, is Associate Professor at Titu Maiorescu University, Faculty of Medicine, Bucharest, and Head of Clinical Hematology Section I at Colentina Clinical Hospital. She defended her habilitation thesis at Titu Maiorescu University, consolidating more than 26 years of clinical and research expertise at the intersection of hemostasis, immunology, and pregnancy. Her work focuses on myeloproliferative neoplasms (JAK2 V617F), thrombophilia, and reproductive immunology, with particular emphasis on recurrent pregnancy loss and high-risk pregnancies. She is the founder of Smart Clinic, a specialized center for high-risk pregnancy care in Bucharest. Dr. Andreescu serves as Secretary of the Hematology Specialty Commission at the Romanian College of Physicians, is a member of the European Hematology Association, and participates in over 20 international clinical trials. Her current research interests extend to immunomodulation in the context of targeted hematological therapies. She has authored more than 70 publications indexed in Web of Science (H-index 8).
Mihaela Andreescu, MD, PhD, is Associate Professor at Titu Maiorescu University, Faculty of Medicine, Bucharest, and Head of Clinical Hematology Section I at Colentina Clinical Hospital. She defended her habilitation thesis at Titu Maiorescu University, consolidating more than 26 years of clinical and research expertise at the intersection of hemostasis, immunology, and pregnancy. Her work focuses on myeloproliferative neoplasms (JAK2 V617F), thrombophilia, and reproductive immunology, with particular emphasis on recurrent pregnancy loss and high-risk pregnancies. She is the founder of Smart Clinic, a specialized center for high-risk pregnancy care in Bucharest. Dr. Andreescu serves as Secretary of the Hematology Specialty Commission at the Romanian College of Physicians, is a member of the European Hematology Association, and participates in over 20 international clinical trials. Her current research interests extend to immunomodulation in the context of targeted hematological therapies. She has authored more than 70 publications indexed in Web of Science (H-index 8).